BETH ISRAEL DEACONESS DEPARTMENT OF NEUROLOGY FOUNDATION INC (EIN 043030397) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1989

Legal Domicile

Principal Officer

SEWARD RUTKOVE MD

Phone

6176675583

Tax Period

2023-10-01 to 2024-09-30

BETH ISRAEL DEACONESS DEPARTMENT OF NEUROLOGY FOUNDATION INC, founded in 1989, is a small nonprofit in the Health Care sector that reported $101K in total revenue in fiscal year 2023. Revenue decreased 10% compared to the prior year. Expenses of $160K exceeded revenue, resulting in a 59% operating deficit.

Mission

THE MISSION OF BETH ISRAEL DEACONESS DEPARTMENT OF NEUROLOGY FOUNDATION, INC. (THE FOUNDATION) IS TO SUPPORT MEDICAL RESEARCH, PROVIDE INSTRUCTION, AND PARTICIPATE IN ACTIVITIES DESIGNED TO IMPROVE THE GENERAL PUBLIC HEALTH OF PATIENTS SERVED BY BETH ISRAEL DEACONESS MEDICAL CENTER, HARVARD MEDICAL FACULTY PHYSICIANS AT BETH ISRAEL DEACONESS MEDICAL CENTER (BIDMC) AND THEIR AFFILIATES. THE FOUNDATION USES ITS FUNDS TO SUPPORT THE PHYSICIAN'S WORK IN THE NEUROLOGY DEPARTMENT AT BIDMC AND TO STRENGTHEN THE DEPARTMENT BY SUPPORTING THE EDUCATIONAL REQUIREMENTS OF THE DEPARTMENT AND PHYSICIANS WORLDWIDE BY PROVIDING TRAINING SEMINARS AND OTHER CLASSES. THE FOUNDATION ALSO USES ITS FUNDS TO SUPPORT EXPENSES INCURRED BY ITS AFFILIATED ENTITIES WHICH BENEFIT THE PHYSICIANS AND OTHER PERSONNEL WHO ARE ENGAGED IN ACTIVITY RELATED TO THE NEUROLOGY FIELD. ALL ACTIVITIES THAT THE FOUNDATION PARTICIPATES IN ARE FOCUSED ON MEDICAL PROCEDURES, RESEARCH, AND OTHER ACTIVITIES THAT ARE INSPIRED TO ENHANCE METHODS UTILIZED IN THE NEUROLOGY FIELD.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $1,500

Program Service Revenue $23,303

Investment Income $76,038

Other Revenue $0

TOTAL REVENUE $100,841

Expense Breakdown

Grants Paid $141,000

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $153,548

Other Expenses $19,492

TOTAL EXPENSES $160,492

Year-over-Year Comparison

	2023	2022	Change
Revenue	$100,841	$111,555	-0.1%
Expenses	$160,492	$161,662	0.0%
Net Income	$-59,651	$-50,107	+0.2%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$1,351,356

Total Directors

$5,453,229

Key Employees

$262,191

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
KIMBALL MD MPH ALEXA B	DIRECTOR (EX-OFFICIO) (HMFP CEO)	1.00	Director	$0	$109,829	$1,199,659
RUTKOVE MD SEWARD	DIR(EX-OFF)& PRES; NEURO CHIEF/CHAIR	1.00	Officer Director	$0	$63,524	$707,472
SELIM MD PHD MAGDY	DIR CHF STROKE & CEREBROVASC BIDMC	1.00	Director	$0	$87,741	$553,440
AGNEW MEGHAN	DIRECTOR; CFO, HFMP	1.00	Director	$0	$89,105	$518,759
FEHNEL MD COREY	DIR; (DIV CHIEF NEURCRIT CARE BIDMC)	1.00	Director	$0	$81,589	$361,082
SIMON MD DAVID	DIR; HMFP MOVEMENT DISORDERS NEURO	1.00	Director	$0	$68,994	$336,975
SCAMMELL MD THOMAS E	DIR & SEC; NEUROLOGIST, SLEEP MED	1.00	Officer Director	$0	$60,416	$319,817
MULLINGTON PHD JANET	DIR; PROG DIR CLIN SLEEP RES CTR BID	1.00	Director	$0	$73,637	$300,726
PRESS MD DANIEL	DIRECTOR; COGNITIVE NEUROLOGIST	1.00	Director	$0	$31,523	$292,559
CHANG MD BERNARD	DIR; CHIEF EPILEPSY & NEURO DIVISION	1.00	Director	$0	$67,968	$251,398
RAYNOR MD ELIZABETH	DIRECTOR; NEUROLOGIST	1.00	Director	$0	$37,248	$221,117
DRISLANE MD FRANK	DIRECTOR; NEUROLOGIST	1.00	Director	$0	$38,754	$196,270
SLOANE MD PHD JACOB	DIRECTOR; NEUROLOGIST	1.00	Director	$0	$20,943	$193,955
HOFFMAN CHRISTOPH	DIRECTOR	1.00	Director	$0	$0	$0
NARAYANASWAMI MD PUSHPA	TREASURER; NEUROLOGIST	1.00	Officer	$0	$61,746	$324,067
FALVEY KERRY	CHIEF ADMINISTRATIVE OFFICER	1.00	Key Emp	$0	$40,584	$262,191
SAPER MD CLIFFORD B	FMR PRES&DIR (EXO); NEURO CHIEF/CHR	0.00		$0	$60,679	$484,794

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$100,841	$160,492	$2,356,179	$-59,651
2023	$111,555	$161,662	$2,158,631	$-50,107
2022	$27,671	$75,349	$1,651,863	$-47,678
2021	$76,132	$17,500	$1,305,031	$58,632
2020	$23,569	$6,037	$1,129,350	$17,532
2019	$27,188	$9,014	$1,117,290	$18,174
2018	$22,823	$7,085	$774,349	$15,738

BETH ISRAEL DEACONESS DEPARTMENT OF NEUROLOGY FOUNDATION INC